DR. WILLIAM JEFFERSON RIETER, M.D., PH.D.
Radiology at Ashley Ave, Charleston, SC
License number
South Carolina LL34810
Category
Osteopathic Medicine
Type
Family Medicine
License number
South Carolina 34810
Category
Radiology
Type
Diagnostic Radiology
Address
Address
2
171 Ashley Ave, Charleston, SC 29425
PO Box 751461, Charlotte, NC 28275
PO Box 751461, Charlotte, NC 28275
Phone
(843) 792-1414
(843) 792-6200
(843) 792-6200
Personal information
See more information about WILLIAM JEFFERSON RIETER at radaris.comName
Address
Phone
25 Charlotte St, Charleston, SC 29403
716 Certificate Ct, Charleston, SC 29414
25 Charlotte St, Charleston, SC 29403
Professional information
See more information about WILLIAM JEFFERSON RIETER at trustoria.com
Dr. William J Rieter, Charleston SC - MD (Doctor of Medicine)
Dr. William J Rieter, Charleston SC - MD (Doctor of Medicine)
Specialties:
Family Medicine
Age:
42
Address:
9228 Medical Plaza Dr, Charleston 29406
(843) 572-8277 (Phone)
MEDICAL UNIVERSITY OF SOUTH CAROLINA
169 Ashley Ave SUITE 202, Charleston 29425
(843) 792-2300 (Phone), (843) 795-4233 (Fax)
(843) 572-8277 (Phone)
MEDICAL UNIVERSITY OF SOUTH CAROLINA
169 Ashley Ave SUITE 202, Charleston 29425
(843) 792-2300 (Phone), (843) 795-4233 (Fax)
Languages:
English
Hospitals:
9228 Medical Plaza Dr, Charleston 29406
MEDICAL UNIVERSITY OF SOUTH CAROLINA
169 Ashley Ave SUITE 202, Charleston 29425
MEDICAL UNIVERSITY OF SOUTH CAROLINA
169 Ashley Ave SUITE 202, Charleston 29425
Education:
Medical School
Medical University of South Carolina
Graduated: 2012
Medical University of South Carolina
Graduated: 2012
William J Rieter, Charleston SC
William J Rieter, Charleston SC
Specialties:
Family Physician
Address:
9228 Medical Plaza Dr, Charleston, SC 29406
Hybrid Nanoparticles As Anti-Cancer Therapeutic Agents And Dual Therapeutic/Imaging Contrast Agents
Hybrid Nanoparticles As Anti-Cancer Therapeutic Agents And Dual Therapeutic/Imaging Contrast Agents
US Patent:
2011013, Jun 9, 2011
Filed:
Feb 23, 2009
Appl. No.:
12/918748
Inventors:
Wenbin Lin - Chapel Hill NC, US
William J. Rieter - Charleston SC, US
William J. Rieter - Charleston SC, US
International Classification:
A61K 9/14, C08F 26/10, B32B 5/00, A61K 31/79, A61K 51/00, A61K 49/00, A61B 5/055, A61K 9/127, C12N 5/00, A61P 35/00, B82Y 5/00
US Classification:
424 165, 525370, 428402, 424 7824, 424 91, 424 93, 424490, 424497, 424450, 435375, 977773, 977906, 977915
Abstract:
The presently disclosed subject matter provides nanoscale coordination polymers for use as anticancer agents and as dual anticancer/imaging agents. The nanoscale coordination polymers can comprise a plurality of platinum metal complexes; nonplatinum anticancer drug bridging ligands complexed to multiple metal centers; or combinations thereof. The nanoscale coordination polymers can be targeted for delivery to cancer cells. They can also comprise stabilizing agents to allow for controlled and/or sustained release of anticancer agents in vivo.
Hybrid Nanomaterials As Multimodal Imaging Contrast Agents
Hybrid Nanomaterials As Multimodal Imaging Contrast Agents
US Patent:
2009031, Dec 24, 2009
Filed:
Apr 20, 2007
Appl. No.:
12/226499
Inventors:
Wenbin Lin - Chapel Hill NC, US
William Rieter - Charleston SC, US
Kathryn Taylor - Chapel Hill NC, US
Jason Kim - Chapel Hill NC, US
William Rieter - Charleston SC, US
Kathryn Taylor - Chapel Hill NC, US
Jason Kim - Chapel Hill NC, US
International Classification:
A61B 5/055, A61K 49/18, G01R 33/44
US Classification:
424 9323, 324307, 977810
Abstract:
The presently disclosed subject matter provides hybrid nanomaterials for use as magnetic resonance imaging (MRI), optical and/or multimodal contrast imaging agents. The hybrid nanomaterials comprise a polymeric matrix material and a plurality of coordination complexes, each coordination complex comprising a functionalized chelating group and a paramagnetic metal ion. The nanoparticle can further comprise a luminophore. Methods of synthesizing and using the nanoparticles are provided. The nanoparticles can be used to diagnose diseases, including cancer, cardiovascular disease, and diseases related to inflammation.